Indian drug manufacturers benefit from Big Pharma interest beyond China
Drugmakers shift reliance from China to India, benefiting Indian CDMOs. Western pharma companies are seeking to limit reliance on Chinese contractors, leading to increased interest in Indian CDMOs.
The Hindu ·
The Hindu
